+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Dermatophytic Onychomycosis Treatment - Global Market Trajectory & Analytics

  • ID: 5140861
  • Report
  • September 2020
  • Region: Global
  • 182 pages
  • Global Industry Analysts, Inc
1 of 2
Global Dermatophytic Onychomycosis Treatment Market to Reach $6.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Dermatophytic Onychomycosis Treatment estimated at US$3 Billion in the year 2020, is projected to reach a revised size of US$6.5 Billion by 2027, growing at a CAGR of 11.8% over the analysis period 2020-2027. Systemic Therapy, one of the segments analyzed in the report, is projected to record a 10.7% CAGR and reach US$2.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Topical Therapy segment is readjusted to a revised 12.6% CAGR for the next 7-year period.

The U. S. Market is Estimated at $874.9 Million, While China is Forecast to Grow at 11.4% CAGR

The Dermatophytic Onychomycosis Treatment market in the U. S. is estimated at US$874.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2027 trailing a CAGR of 11.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.3% and 10.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.7% CAGR.

Device-based Therapy Segment to Record 11.2% CAGR

In the global Device-based Therapy segment, USA, Canada, Japan, China and Europe will drive the 11% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$89.8 Million in the year 2020 will reach a projected size of US$186.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$771 Million by the year 2027. We bring years of research experience to this 9th edition of our report. The 182-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • Allergan PLC
  • Galderma SA
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Moberg Pharma AB
  • NovaBiotics Ltd
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi SA
  • Valeant Pharmaceuticals International, Inc.
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Global Competitor Market Shares
  • Dermatophytic Onychomycosis Treatment Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 2: World Historic Review for Dermatophytic Onychomycosis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 3: World 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • TABLE 4: World Current & Future Analysis for Systemic Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 5: World Historic Review for Systemic Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 6: World 15-Year Perspective for Systemic Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • TABLE 7: World Current & Future Analysis for Topical Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 8: World Historic Review for Topical Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 9: World 15-Year Perspective for Topical Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • TABLE 10: World Current & Future Analysis for Device-based Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 11: World Historic Review for Device-based Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 12: World 15-Year Perspective for Device-based Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • TABLE 13: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 15: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • TABLE 16: World Current & Future Analysis for Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 17: World Historic Review for Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 18: World 15-Year Perspective for Dermatology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • TABLE 19: World Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 20: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 21: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • TABLE 22: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 24: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US Dermatophytic Onychomycosis Treatment Market Share (in %) by Company: 2019 & 2025
  • Market Analytics
  • TABLE 25: USA Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 26: USA Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 27: USA 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Systemic Therapy, Topical Therapy and Device-based Therapy for the Years 2012, 2020 & 2027
  • TABLE 28: USA Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 29: USA Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 30: USA 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses for the Years 2012, 2020 & 2027
CANADA
  • TABLE 31: Canada Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 32: Canada Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 33: Canada 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Systemic Therapy, Topical Therapy and Device-based Therapy for the Years 2012, 2020 & 2027
  • TABLE 34: Canada Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 35: Canada Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 36: Canada 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses for the Years 2012, 2020 & 2027
JAPAN
  • TABLE 37: Japan Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 38: Japan Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 39: Japan 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Systemic Therapy, Topical Therapy and Device-based Therapy for the Years 2012, 2020 & 2027
  • TABLE 40: Japan Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 41: Japan Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 42: Japan 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses for the Years 2012, 2020 & 2027
CHINA
  • TABLE 43: China Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 44: China Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 45: China 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Systemic Therapy, Topical Therapy and Device-based Therapy for the Years 2012, 2020 & 2027
  • TABLE 46: China Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 47: China Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 48: China 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses for the Years 2012, 2020 & 2027
EUROPE
  • Market Facts & Figures
  • European Dermatophytic Onychomycosis Treatment Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Market Analytics
  • TABLE 49: Europe Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 50: Europe Historic Review for Dermatophytic Onychomycosis Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 51: Europe 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • TABLE 52: Europe Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 53: Europe Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 54: Europe 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Systemic Therapy, Topical Therapy and Device-based Therapy for the Years 2012, 2020 & 2027
  • TABLE 55: Europe Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 56: Europe Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 57: Europe 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses for the Years 2012, 2020 & 2027
FRANCE
  • TABLE 58: France Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 59: France Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 60: France 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Systemic Therapy, Topical Therapy and Device-based Therapy for the Years 2012, 2020 & 2027
  • TABLE 61: France Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 62: France Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 63: France 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses for the Years 2012, 2020 & 2027
GERMANY
  • TABLE 64: Germany Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 65: Germany Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 66: Germany 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Systemic Therapy, Topical Therapy and Device-based Therapy for the Years 2012, 2020 & 2027
  • TABLE 67: Germany Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 68: Germany Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 69: Germany 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses for the Years 2012, 2020 & 2027
ITALY
  • TABLE 70: Italy Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 71: Italy Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 72: Italy 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Systemic Therapy, Topical Therapy and Device-based Therapy for the Years 2012, 2020 & 2027
  • TABLE 73: Italy Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 74: Italy Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 75: Italy 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses for the Years 2012, 2020 & 2027
UNITED KINGDOM
  • TABLE 76: UK Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 77: UK Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 78: UK 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Systemic Therapy, Topical Therapy and Device-based Therapy for the Years 2012, 2020 & 2027
  • TABLE 79: UK Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 80: UK Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 81: UK 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses for the Years 2012, 2020 & 2027
REST OF EUROPE
  • TABLE 82: Rest of Europe Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 83: Rest of Europe Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 84: Rest of Europe 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Systemic Therapy, Topical Therapy and Device-based Therapy for the Years 2012, 2020 & 2027
  • TABLE 85: Rest of Europe Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 86: Rest of Europe Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 87: Rest of Europe 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses for the Years 2012, 2020 & 2027
ASIA-PACIFIC
  • TABLE 88: Asia-Pacific Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 89: Asia-Pacific Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 90: Asia-Pacific 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Systemic Therapy, Topical Therapy and Device-based Therapy for the Years 2012, 2020 & 2027
  • TABLE 91: Asia-Pacific Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 92: Asia-Pacific Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 93: Asia-Pacific 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses for the Years 2012, 2020 & 2027
REST OF WORLD
  • TABLE 94: Rest of World Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 95: Rest of World Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Systemic Therapy, Topical Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 96: Rest of World 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Systemic Therapy, Topical Therapy and Device-based Therapy for the Years 2012, 2020 & 2027
  • TABLE 97: Rest of World Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 98: Rest of World Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 99: Rest of World 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Retail Pharmacies and Other End-Uses for the Years 2012, 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 44
Note: Product cover images may vary from those shown
Adroll
adroll